Newsletters

BACK TO NEWSLETTERS

Newsletter

News-At-A-Glance

Date: December 13th, 2016

President Obama signed the 21st Century Cures Act into law on December 13, 2016. The Cures Act will hasten how drugs and medical devices are reviewed and authorized by the Food and Drug Administration (FDA). The Alliance recently released a statement on the Cures Act. Read it here.    Last month, the ACT-AD (Accelerate Cures/Treatments for Alzheimer's Disease) Coalition hosted its Ninth Annual FDA/Alzheimer's Disease Allies Meeting to discuss the current state of Alzheimer's disease treatment development. You can find a full recap


Alliance Annual Dinner Highlights Caregivers, Alzheimer’s Research

Date: December 7th, 2015

The Annual Bipartisan Congressional Awards Dinner is a time-honored tradition at the Alliance for Aging Research. Over the years, the dinner has brought to the stage of the historic Willard Hotel notable government officials such as Senators John Glenn and Edward Kennedy, extraordinary innovators like Jay Walker and Martha Stewart, and heads of critical health agencies that include the FDA, NIH, CMS, and even NASA. On September 29, 2015, the Alliance continued the tradition of celebrating the cause of aging research and honoring


Helping Stop a Devastating Disease: The ACT-AD Coalition Continues its Important Work in Alzheimer's Disease

Date: February 1st, 2013

Alzheimer's disease is a slow, dehumanizing, and fatal disease that strikes 1 in 8 people over the age of 65. While it's typically thought of as a disease that affects memory, it goes well beyond memory loss and eventually leads to death. The disease progresses gradually as abnormal proteins—called plaques and tangles—accumulate in the brain and kill healthy cells. It starts out in the part of the brain where memories are formed, which is often the time when an individual seeks


Alzheimer's Treatment and Care at a Crossroads: Pursuing All Avenues to Provide Relief

Date: October 1st, 2012

If you or a loved one has been diagnosed with Alzheimer’s disease, you’ve most likely wondered if there are any ways to relieve some of the burden of the disease, in addition to the pills to manage its symptoms. For many diseases like heart disease and diabetes, changes to diet and exercise are as high on health care providers list of advice for patients as a prescription for medication, but this isn’t the case with how they approach Alzheimer’s disease. You


Battling Health Disparities: Closing the Gaps

Date: July 1st, 2009

Thanks to enormous advances in public health and exciting breakthroughs in medical innovation, over the past century Americans have seen dramatic gains in health and longevity. The United States currently spends more on health care than any other nation and for most people, this means access to one of the best health care systems in the world. Unfortunately, it doesn’t benefit all people equally and the reality is that most minorities have less access to care, fewer options for prevention


Stopping Alzheimer's: What Can You Do?

Date: May 1st, 2008

With the aging of the population, experts warn that Alzheimer’s disease will reach epidemic proportions by mid-century, creating massive and unsustainable burdens in terms of health care costs, overwhelmed families, and millions of lives tragically lost to a devastating disease. According to the Alzheimer’s Association’s latest report, 5.2 million Americans already have Alzheimer’s and as they age, one in eight baby boomers will develop this devastating and fatal disease. And despite the fact that the disease was discovered more than 100 years ago,


Better Treatments Sought for Neurological Diseases

Date: February 1st, 2007

William Shakespeare famously described life’s seven stages, none of them in especially happy terms. The final stage of old age is “second childishness and mere oblivion/Sans teeth, sans eyes, sans taste, sans everything.” Most people with neurological conditions aren’t quite that decrepit, but Shakespeare’s words from “As You Like It” seem to capture accurately the helplessness of mind and body that gradually overtakes people with Alzheimer’s disease and Parkinson’s disease. So far, there are no cures for these two most common neurological


Make Alzheimer's a National Priority

Date: July 1st, 2006

A Pending Epidemic It’s a disease that is universally fatal; there is no cure at present; and one out of 10 people over 65 will be diagnosed with it. It already affects millions of Americans at the cost of billions, and as baby boomers swell the ranks of the elderly, it could potentially break our health care system. But it has yet to be recognized as a national health priority. "It" is Alzheimer’s disease (AD), a devastating neurological disease that destroys brain


New Frontiers in Battle Against Alzheimer's

Date: April 1st, 2002

New Alzheimer's research is making dramatic strides in treating one of the most common - and feared - forms of dementia. The degenerative brain disease strikes one in 10 of those over 65, and almost half of those over 85. Alzheimer's currently affects some 4 million Americans, but experts predict that number could grow to 14 million in the next 50 years unless a cure or preventive treatment is found. Research is focusing on three main areas: What causes the brain to


Alzheimer's Disease: The Cruelest Thief

Date: October 1st, 2001

Alzheimer's is the cruelest of the diseases that strike the elderly. There is no known cure for this neuro-degenerative disorder that eats away the body's command center, first stealing memory, then bodily functions, and ultimately life as it runs its course over five to 15 years. It holds five million people hostage - most of them past age 70 - and ranks 4th in cause of death for Americans. It is estimated that 10 percent of people past age 65


A Shot of Hope on the Alzheimer's Front

Date: October 1st, 1999

Vaccine In Mice Study Proves Promising This is not the case of the mouse that roared, but instead the one where the mouse stayed plaque-free. Plaque is a big thing in the world of Alzheimer's research. Deposits known as amyloid plaques are found in the brain, but whether they cause the symptoms of the illness or simply signal the presence of the disease is unclear. However, scientists recently developed and administered a new vaccine to mice with promising results. Seven of nine showed